Preo Pharma ApS

CVR number: 41191007
Langelinie Allé 7, 2100 København Ø

Income statement (kDKK)

202020212022
Fiscal period length121212
Net sales
Gross profit- 160.99294.88-41.28
EBIT- 160.99294.88-41.28
Other financial expenses-2.11-11.30-13.02
Reduction non-current investment assets-32.54
Pre-tax profit- 163.10251.04-54.30
Income taxes43.01-62.39
Net earnings- 120.08188.66-54.30

Assets (kDKK)

202020212022
Intangible assets total
Tangible assets total
Investments total
Long term receivables total
Inventories total
Current other receivables2.820.200.43
Current deferred tax assets19.24
Short term receivables total22.060.200.43
Cash and bank deposits110.39376.54343.58
Cash and cash equivalents110.39376.54343.58
Balance sheet total (assets)132.46376.74344.01

Equity and liabilities (kDKK)

202020212022
Share capital40.0040.0040.00
Retained earnings- 120.0868.57
Profit of the financial year- 120.08188.66-54.30
Shareholders equity total-80.08108.5754.27
Non-current liabilities total
Current owed to group member178.13228.52228.25
Other non-interest bearing current liabilities34.4139.6461.50
Current liabilities total212.54268.16289.74
Balance sheet total (liabilities)132.46376.74344.01
Try the full version of our system for free
Bankruptcy risk visualization example

... and more!

No registration needed.